applications published 24 january 2007
Cosmetic and/or dermatological preparation and use thereof in the regulation of skin capillary blood flow
Otkrytoe Aktsionernoe Obschestvo Faberlic 1744726*
Controlled release compsns
Dow Corning 1744727*
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
Flamel Technologies 1744729*
Pharmaceutical compsns for glucocorticoid replacement therapy
Duocort 1744730*
Oral formulation for delivery of poorly absorbed drugs
Procarrier 1744731*
Nutritional compsn for increasing creatine uptake in skeletal muscle
Thermo Formulations 1744732*
Softgel encapsulated pharmaceutical compsns comprising concentrated active ingredients
Procter & Gamble 1744733*
Therapeutic compsns comprising a tissue factor antagonist and anti-cancer compounds
Novo Nordisk 1744734*
Method of treating myocardial infarction
The Scripps Research Institute 1744735*
Method of treating dry eye disorders and uveitis
Alcon 1744736*
Cysteamines for treating complications of hypercholesterolemia and diabetes
Omega Bio-Pharma 1744737*
Topical preparation containing ambroxol
Boehringer Ingelheim International 1744738*
Use of treprostinol to treat neuropathic diabetic foot ulcers
United Technologies 1744739*
Phenoxyalkylcarboxylic acid derivatives in the treatment of inflammatory diseases
Medicinova 1744740*
Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer
Allos Therapeutics 1744741*
Crystalline and amorphous forms of efaproxiral sodium
Allos Therapeutics 1744742*
Pharmaceutical solution formulations containing 17-AAG
Kosan Biosciences 1744743*
Bioactive compounds and methods of use thereof
Rutgers, the State University of New Jersey; Regents of the University of Minnesota; Wellgen 1744744*
Pharmaceutical nitrones
Children's Hospital and Research Center at Oakland 1744745*
Use of melatonin in preventing postoperative complications
Nutri-Fit 1744746*
Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
Vanderbilt University 1744747*
Method of using and compsns comprising selective cytokine inhibitory drugs for the treatment and management of myelodysplastic syndromes
Celgene 1744748*
Methods of using and compsns containing immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
Celgene 1744749*
Pharmaceutical compsns comprising hydrophobic drug having improved solubility
Sandoz 1744750*
Methods for the treatment of synucleinopathies
The Brigham and Women's Hospital 1744751*
A method for the prevention of thromboembolic disorders
Orion 1744752*
A method for the treatment or prevention of cardiac hypertrophy
Orion 1744753*
Morpholine compounds
Pfizer 1744754*
Compounds and compsns as cathepsin S inhibitors
IRM 1744755*
Use of meloxicam formulations in veterinary medicine
Boehringer Ingelheim Vetmedica 1744756*
Improved NSAID compsn
Equitech 1744757*
Radiopharmaceuticals and methods of synthesis and use thereof
PerkinElmer 1744758*
Use of loteprednol etabonate for the treatment of dry eye
Bausch & Lomb 1744759*
Pharmaceutical compsns for acute glucocorticoid therapy
Duocort 1744760*
Methods for treating or preventing restenosis and other vascular proliferative disorders
Molecules for Health; The Ohio State University Research Foundation 1744761*
Transgenic models of Alzheimer's disease and uses thereof in the treatment of a variety of neurodegenerative disorders
Buck Institute 1744762*
Spinosyns for wound healing
Eli Lilly 1744763*
Liposomal formulations of anthracycline agents and cytidine analogues
Celator Pharmaceuticals 1744764*
Materials for medical implants and occlusive devices
Clarity 1744765*
Compsn for stimulating bone growth and differentiation and method for isolating the same
The University of Queensland 1744766*
Therapeutic delivery system comprising a high molecular weight PEG-like compound
The University of Chicago 1744767*
Peritoneal dialysis solution
Fresenius Medical Care Deutschland 1744768*
Non-staining topical iodine compsn
Symbolion 1744769*
High yield and rapid synthesis methods for producing metallo-organic salts
Osteologix 1744770*
Self-assembled nanotubes and methods for preparing the same
NanoDynamics 1744771*
Flaxseeds for body weight management
Den KGL Veterinaer-OG Landbohojskole 1744772*
Preparation and therapeutic uses of plants and plant extracts in the hylocereus genus
Cephymed; Institut Malgache de Recherches Appliquees 1744773*
Nutritional compsn which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite
New HC Formulations 1744774*
Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency
Laboratoires Expanscience 1744775*
Neurotransmitter mixture which promotes the healing of wounds
Schmolz, Dr Manfred 1744776*
Use of IL-6 in the preparation of pharmaceutical compsns for treating and preventing liver injury
Applied Research Systems 1744777*
Use of growth hormone in treatment of long-bone fractures
Novo Nordisk 1744778*
Lytic enzymes and spore surface lytic enzymes for detection and treatment of Bacillus anthracis. bacteria and spores
The Rockefeller University 1744779*
Cancer treatment using viruses and camptothecins
Wellstate Biologics 1744780*
Treatment of infectious diseases
BKG Pharma Aps 1744781*
Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof
Hanmi Pharm 1744782*
Compsns comprising cells and magnetic materials for targeted delivery
Magnet Attraction 1744783*
Formulations of anti-pain agents and methods of using the same
Becton, Dickinson and Co 1744784*
Hydroxyalkyl derivatives of biologically active compounds
Kopran Research Laboratories 1744785*
Chemically modified protein compsns and methods
Amgen 1744786*
Polymeric coupling agents and pharmaceutically-active polymers made therefrom
Interface Biologics 1744787*
Combinatorial methods and compsns for treatment of melanoma
The Penn State Research Foundation 1744788*
Activatable particles, preparations and uses
Nanobiotix 1744789*